Forum

Welcome to the Cannabis Investing Newsletter Forum. Feel free to find your favorite cannabis stocks and contribute content as you please; content that continues the discussion of and analysis of cannabis stocks. – D. H. Taylor

Notifications
Clear all

Cronos Group CRON stock is profitable and whether to buy now!


D. H. Taylor
(@cannabisinvestingnewsletter)
Member Admin
Joined: 1 year ago
Posts: 260
Topic starter  

Cronos Group CRON stock was profitable this quarter despite the inability to actually be profitable.  The core business is a losing proposition at this point despite the marijuana stock being in business since 2012 and having expanded into adult-use cannabis in Canada in 2018.

Time is money.  Cronos CRON stock has every reason to continue lower from the current price.  But, eventually, CRON stock may turn around.  Should you wait this out, buy now?  Or, should you realize that time is money and getting involved in CRON stock may be a loss of both time and money.  Cronos Group flipped in Canada in 2018 to try and take on the adult-use segment of cannabis.  Cronos Group was not necessarily profitable before that move.  Now that Cronos Group is involved in the legal cannabis industry, and after three years of pursuing this, Cronos Group is no where near profitable.

Cronos Group CRON stock is a popular stock and may have gotten caught up in the hype of cannabis initially.  It is a very popular stock.  And, I think that because CRON trades on NASDAQ it has drawn in a lot of attention to the bigger players.  Maybe that is not always a good idea.

This topic was modified 6 days ago by D. H. Taylor

Quote
Russell
 Russell
(@Russell)
Guest
Joined: 3 months ago
Posts: 1
 

Almost all Cannabis stocks have been tanking the past few months even though their financials are getting stronger with more and more expansion. When do you think we will see a turn around ?


ReplyQuote
Joe Wocoski
 Joe Wocoski
(@Joe Wocoski)
Guest
Joined: 3 months ago
Posts: 1
 

In my opinion by year end at the latest: Legal action pressure is mounting against cannabis being a schedule 1 drug: Right now the democrates and the new heads of the FDA, DEA, DOJ, DOV are supportive of some form of legalization, as are all states except 4 republican states. Senator's know voting against their state wishes will loose them re-election in 2022. Senate Discussions start in September.
There are two under the radar federal legal cases challenging the constitutionality of the only obstacles to legalization... the DEA legal ban on cannabis which coming up for trial September 30, 2021, the Judges asked for constitutional comments about DEA violating States Rights. It appears evident that if courts will find against DEA then will order DEA to immediately remove Cannabis from being a schedule 1 drug, thus making it legal and forcing congress to enact legislation by year end.


ReplyQuote
Bryan Martin
(@bryan-martin75gmail-com)
New Member
Joined: 3 months ago
Posts: 1
 

I agree, I just subscribed primarily to here some current analysis on the cannabis sell off taking place. Most companies seem to be getting more profitable while legislation continues to (slowly) gain momentum, yet stock prices are going down. Is this the big players taking profits during worldwide uncertainty, or something else?


ReplyQuote
Share: